Skip to main content
. Author manuscript; available in PMC: 2021 Dec 9.
Published in final edited form as: Clin Cancer Res. 2014 May 29;20(14):3753–3762. doi: 10.1158/1078-0432.CCR-13-3042

Table 1.

Clinical stage of oral MM from dogs included in the study

Group Stage II Stage III
Overall population (n=33) 10 (30.3)a 23 (69.7)a
Group Ib (n=14) 5 (35.7) 9 (64.3)
Group IIc (n=13) 3 (23.1) 10 (76.9)
Group IIId (n=6) 2 (33.3) 4 (66.7)
Group II+III (n=19) 5 (26.3) 14 (73.7)
a

% in brackets

b

CSPG4-positive MM; vaccinated dogs

c

CSPG4-positive MM; non vaccinated dogs

d

CSPG4-negative MM; non vaccinated dogs